Clinical Trial Update: Collaborative Ocular Melanoma Study (COMS) [Phase 3]

View source ↗

Summary

This entry provides an update on the Phase 3 Collaborative Ocular Melanoma Study (COMS) involving ocular/choroidal neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neoplasms
• Uveitis

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Choroid Neoplasms, Uveitis | Phase 3 | Status: UNKNOWN